DRD2 activation inhibits choroidal neovascularization in patients with Parkinson’s disease and age-related macular degeneration. - Mathis, Thibaud; Baudin, Florian; Mariet, Anne-Sophie; Augustin, Sébastien; Bricout, Marion; Przegralek, Lauriane; Roubeix, Christophe; Benzenine, Éric; Blot, Guillaume; Nous, Caroline; Kodjikian, Laurent; Mauget-Faÿsse, Martine; et al. (Journal of Clinical Investigation, 2024)